maytansine and geldanamycin

Supplementing a culture of a mutant strain of Actinosynnema pretiosum that is unable to biosynthesize aminohydroxy benzoic acid (AHBA), with 3-azido-5-hydroxy-benzoic acid and 3-azido-5-amino-benzoic acid, unexpectedly yielded anilino ansamitocins instead of the expected azido derivatives. This is the first example of the bioreduction of organic azides. The unique nature of these results was demonstrated when 3-azido-5-amino-benzoic acid was fed to the corresponding AHBA blocked mutant of Streptomyces hygroscopicus, the geldanamycin producer. This mutasynthetic experiment yielded the fully processed azido derivative of geldanamycin.

Topics: Aminobenzoates; Anti-Bacterial Agents; Azides; Benzoquinones; Drug Screening Assays, Antitumor; Hydroxybenzoates; Lactams, Macrocyclic; Maytansine; Molecular Structure; Streptomyces

Topics: Actinomycetales; Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Humans; Lactams, Macrocyclic; Maytansine; Mutation; Neoplasms; Streptomyces; Tubulin Modulators